| 英文名称 | 中文名称 | CAS | MF |
|
decathymidylic acid
|
|
|
|
|
deca-1,4,9-triene
|
|
10124-98-8
|
C10H16
|
|
DECATONE
|
八氢化-6-(1-甲基乙基)-2(1H)萘酮
|
34131-98-1
|
C13H22O
|
|
1,5,9-DECATRIENE
|
1,5,9-癸三烯
|
13393-64-1
|
C10H16
|
|
DECA-2,4,6,8-TETRAENAL
|
|
40650-87-1
|
C10H12O
|
|
2,4,6,8-DECATETRAENOIC ACID
|
2,4,6,8-十四四烯酸
|
17016-39-6
|
C10H12O2
|
|
1,3,5-Decatriene
|
|
72084-26-5
|
|
|
decatromicin B
|
|
235097-64-0
|
|
|
6α-(1,3,5,7-Decatetrenyl)-1,2α-dimethylpiperidin-3α-ol
|
|
|
|
|
2,4,6-Decatriynedioic acid
|
|
3943-58-6
|
|
|
2,4,6,8-Decatetryne
|
|
24442-76-0
|
|
|
DDMAU
|
|
|
C25H51NO2
|
|
DECAV protocol
|
|
|
|
|
Decay Accelarating Factor (DAF), CD55, Hematopoitic & non-hematopoetic Cell, Cl.: 143-30, Mab anti-Human
|
|
|
|
|
DEBLOCKING REAGENT
|
|
|
C3H4Cl4O2
|
|
DEBLOCK SOLUTION
|
|
|
|
|
Dichloromethane
|
二氯甲烷
|
75-09-2
|
CH2Cl2
|
|
DEA (WEAK ANION), 10ML LRC COLUMN 100 MG
|
|
|
|
|
Decay Accelarating Factor (DAF), CD55, Hematopoitic & non-hematopoetic Cell, Cl.: 143-30, Mab anti-Human, RPE
|
|
|
|
|
DEA (WEAK ANION), 10ML LRC COLUMN 500 MG
|
|
|
|
|
Decay Accelarating Factor (DAF), CD55, Hematopoitic & non-hemat. Cell, Clone: BRIC-216, Mab anti-Human
|
|
|
|
|
Decay Accelarating Factor, CD55,Hematopoeitic and non-Hematopoietic Cells,gp 70,Cl.: BRIC 110,Mab anti-Hu.
|
|
|
|
|
Decay Accelarating Factor, CD55, Hematopoitic & non-hematopoetic Cell, Cl: BRIC216, Mab anti-Hu., Blocks, flw/IP/WB
|
|
|
|
|
Decay Accelarating Factor, CD55, Hematopoitic & non-hematopoetic Cell, Clone: 67, Mab anti-Human, RPE, flow
|
|
|
|
|
Decay Accelarating Factor (DAF), CD55, Hematopoitic & non-hematopoetic Cell, Cl.: 143-30, Mab anti-Human, RPE/Cy5
|
|
|
|
|
Decay Accelarating Factor (DAF), CD55, Hematopoitic & non-hematopoetic Cell, Cl.: 143-30, Mab anti-Human, FITC
|
|
|
|
|
Decay Accelarating Factor, CD55, GPI-linked 70kD, Clone: MEM-118, Mab anti-Human
|
|
|
|
|
Decay Accelarating Factor, CD55, Hematopoitic & non-hematopoetic Cell, Clone: 67, Mab anti-Human, flow
|
|
|
|
|
Decay Accelarating Factor, CD55,Hematopoeitic and non-Hematopoietic Cells,gp 70,Cl.: BRIC 110,Mab anti-Hu., FITC
|
|
|
|
|
DEC-205,CLONE:11A10,MABANTI-HUMAN:PARAFFIN
|
|
|
|
|
DEC1 (Deleted in Esophageal Cancer 1), ~20kD, Goat anti-Human, WB
|
|
|
|
|
Debneyol
|
|
|
C15H26O2
|
|
DEB-M protocol
|
|
|
|
|
D,DM,CZ,TMTD,NS,ZDEC,DPG,PVI,6PPD,1PPD,etc.
|
|
|
|
|
7-deaza-R34
|
|
|
|
|
3-deaza-5'-noraristeromycin
|
|
|
|
|
7-Deaza-2'-deoxy-D-inosine
|
|
|
|
|
9-deaza-9-(3-thienylmethyl)guanine
|
|
132138-76-2
|
C11H10N4OS
|
|
7-deazaxanthine
|
|
|
|
|
7-Deaza-2',3'-dideoxy-D-guanosine
|
|
|
|
|
3-deazacytidine
|
|
28307-19-9
|
|
|
7-DEAZA-2'-DEOXYINOSINE, [8-3H(N)]-
|
|
|
C11H12N3O4T
|
|
7-DEAZAGUANOSINE, [8-3H(N)]-
|
|
|
C11H13N4O5T
|
|
8-deazafolic acid
|
|
51989-25-4
|
|
|
7-deaza-dGTP
|
|
|
|
|
7-DEAZA-SS-D-2'',3''-DIDEOXYGUANOSINE, HPLC PURIFIED, 98% PURE WITH HPLC UV CHROMATOGRAM
|
|
|
|
|
7-DEAZA-BETA-D-2',3'-DIDEOXYGUANOSINE
|
|
|
C11H14N4O3
|
|
7-DEAZA-2''-DEOXYINOSINE, HPLC PURIFIED, 98% PURE WITH HPLC UV CHROMATOGRAM
|
|
|
|
|
7-DEAZA-SS-D-2'',3''-DIDEOXYADENOSINE, HPLC PURIFIED, 98% PURE WITH HPLC UV CHROMATOGRAM
|
|
|
|
|
7-deaza-8-bromo-cyclic ADP-ribose
|
|
|
|
|
3-deazaguanosine
|
|
56039-11-3
|
C11H14N4O5
|
|
7-DEAZA-7-IODO-2''-DEOXYGUANOSINE, HPLC PURIFIED, 98% PURE WITH HPLC UV CHROMATOGRAM
|
|
|
|
|
7-DEAZA-7-IODO-2''-DEOXYADENOSINE, HPLC PURIFIED, 98% PURE WITH HPLC UV CHROMATOGRAM
|
|
|
|
|
7-DEAZA-6-METHOXY-2''-DEOXYGUANOSINE, HPLC PURIFIED, 98% PURE WITH HPLC UV CHROMATOGRAM
|
|
|
|
|
9-DEAZA-2''-DEOXYGUANOSINE
|
|
|
|
|
5-deazaaminopterin
|
|
80360-09-4
|
|
|
7-DEAZA-2-MERCAPTO-HYPOXANTHINE
|
|
|
C6H5N3OS
|
|
7-deaza-9-(2-hydroxy-3-nonyl)adenine
|
|
103298-51-7
|
|
|
3-deazacyclopentenylcytosine
|
|
130378-89-1
|
|
|
7-DEAZA-2',3'-DIDEOXYADENOSINE, [8-3H(N)]-
|
|
|
C11H13N4O2T
|
|
7-DEAZAINOSINE, [8-3H(N)]-
|
|
|
C11H12N3O5T
|
|
7-Deaza-2',3'-dideoxy-D-adenosine
|
|
|
|
|
8-deazahomofolic acid
|
|
111113-73-6
|
|
|
7-Deaza-2'-deoxy-7-iodo-D-guanosine
|
|
|
|
|
DEAZAPURINE
|
7H-吡咯并[2,3-D]嘧啶
|
271-70-5
|
C6H5N3
|
|
7-DEAZAGUANOSINE
|
|
102731-45-3
|
C11H14N4O5
|
|
DCVP-1-asp protocol
|
|
|
|
|
3-deaza-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine
|
|
137427-72-6
|
|
|
7-DEAZA-2'-DEOXYXANTHOSINE
|
|
96022-82-1
|
C11H13N3O5
|
|
5-deazaflavin 4,5-epoxide
|
|
86889-50-1
|
|
|
7-deaza-2'-deoxyinosine triphosphate
|
|
136120-28-0
|
|
|
3-deaza-6-azauridine
|
|
56707-91-6
|
|
|
3-deazauridine 5'-triphosphate
|
|
54267-16-2
|
|
|
7-DEAZAGUANOSINE-5'-TRIPHOSPHATE LITHIUM SALT
|
|
|
C11H13Li4N4O14P3
|
|
7-DEAZAGUANOSINE
|
|
62160-23-0
|
C11H14N4O5
|
|
3-DEAZAADENOSINE, [3H]-
|
|
|
C11N4O4T14
|
|
1-deazaadenosine
|
1-去氮杂腺苷
|
14432-09-8
|
C11H14N4O4
|
|
7-DEAZA-6-METHOXY-2'-DEOXYGUANOSINE, [8-3H(N)]-
|
|
|
C12H15N4O4T
|
|
7-DEAZAADENOSINE, [3H]-
|
|
|
C11H13N4O4T
|
|
3-DEAZA-DA CEP
|
|
666257-76-7
|
C48H53N6O7P
|
|
Deaza-Aminopterin
|
|
18921-68-1
|
C21H22N6O5
|
|
7-Deaza-2'-deoxynucleoside-5'-triphosphate
|
|
|
|
|
7-deaza cyclic adenosine 5'-diphosphate ribose
|
|
|
|
|
7-DEAZA-2'-DEOXYADENOSINE-5'-TRIPHOSPHATE LITHIUM SALT
|
|
|
C11H16LiN4O12P3
|
|
3-DEAZANEPLANOCIN, [3H]-
|
|
|
C12N4O3T16
|
|
7-DEAZA-2'-DEOXYADENOSINE, [8-3H(N)]-
|
|
|
C11H13N4O3T
|
|
1-deaza-FMN
|
|
70805-82-2
|
|
|
DdMEK1
|
|
|
|
|
3-deaza-2'-deoxycytidine
|
|
29868-19-7
|
|
|
7-DEAZA-7-CARBAMOYLADENOSINE HYDRATE
|
|
|
C12H17N5O6
|
|
9-deazainosine
|
|
89458-19-5
|
|
|
5-deazariboflavin
|
|
19342-73-5
|
|
|
5-deazamethotrexate
|
|
|
|
|
11-deazahomofolic acid
|
|
119770-54-6
|
|
|
7-deazainosine
|
7-去氮肌苷
|
2862-16-0
|
C11H13N3O5
|
|
7-DEAZAADENOSINE-5'-TRIPHOSPHATE LITHIUM SALT
|
|
|
C11H13Li4N4O13P3
|
|
3-deaza-2'-deoxyguanosine
|
|
83587-63-7
|
|
|
3-deaza-4-deoxyuridine
|
|
5116-37-0
|
|
|
7-DEAZA-2'-DEOXYXANTHOSINE CEP
|
|
676456-10-3
|
C41H48N5O8P
|
|
7-DEAZA-7-IODO-2'-DEOXYGUANOSINE
|
7-DEAZA-7-碘-2'-脱氧腺苷
|
172163-62-1
|
C11H13IN4O4
|